Moderna Newsroom

FDA Is Said to Clear Updated COVID Shots as Early as Next Week

Seeking Alpha13:54 ET

Pfizer, BioNTech Hit Roadblock in COVID-flu Vaccine Trial

Yahoo FinanceAug 16 16:21 ET

Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study

BenzingaAug 16 09:19 ET

The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.

Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.

cls.cnAug 16 07:37 ET

Goldman Sachs lowered the target price for Moderna to $88.

JPMorgan has lowered Moderna's target price from $96 to $88 and maintains a "neutral" rating.

Gelonghui FinanceAug 16 05:33 ET

Pfizer and Moderna Covid-19 Vaccines Usage and Updated Safety Labels

Yahoo FinanceAug 16 00:22 ET

J.P. Morgan Maintains Moderna(MRNA.US) With Hold Rating, Raises Target Price to $88

Moomoo NewsAug 15 20:31 ET · Ratings

Express News | Shares of Vaccine Companies Are Trading Higher After Sweden Reported the First Mpox Clade 1 Case Outside Africa

BenzingaAug 15 13:59 ET

Moderna Was the Most Shorted S&P 500 Healthcare Stock in July

Seeking AlphaAug 15 13:47 ET

Express News | Vaccine Group Gavi Says It Has Up To $500M Available For Mpox Response

BenzingaAug 15 13:02 ET

Demystifying Moderna: Insights From 11 Analyst Reviews

BenzingaAug 15 13:00 ET

Moderna, Inc. (NASDAQ:MRNA) Is a Favorite Amongst Institutional Investors Who Own 67%

Yahoo FinanceAug 15 09:00 ET

Here Are Top Institutions' Q2 Stock Buys And Sells by 13F Filings

Moomoo News GlobalAug 15 08:35 ET

Evercore Maintains Moderna(MRNA.US) With Hold Rating, Maintains Target Price $105

Moomoo NewsAug 15 08:31 ET · Ratings

Moderna Analyst Ratings

BenzingaAug 15 08:08 ET · Ratings

JPMorgan Adjusts Price Target on Moderna to $88 From $96, Maintains Neutral Rating

MT NewswiresAug 15 06:49 ET · Ratings

Express News | Moderna : JP Morgan Cuts Target Price to $88 From $96

ReutersAug 15 00:32 ET

Express News | WHO Says Expert Committee Will Propose Adoption Of Mpox Vaccines Under Emergency Use Listing Around Mid Sept

BenzingaAug 14 13:55 ET

Express News | WHO Director-General Tedros Adhanom Ghebreyesus Says Mpox Is Public Health Emergency Of International Concern

BenzingaAug 14 13:27 ET

Express News | WHO Press Conference On Potential Mpox Emergency Declaration Begins

BenzingaAug 14 13:25 ET